Neonatal Research Center, Department of Pediatrics, David Geffen School of Medicine University of California Los Angeles, USA.
Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E489-98. doi: 10.1152/ajpendo.00361.2009. Epub 2009 Dec 15.
Prenatal nutrient restriction with intrauterine growth restriction (IUGR) alters basal and glucose-stimulated insulin response and hepatic metabolic adaptation. The effect of early intervention with insulin-sensitizing peroxisome proliferator-activated receptor gamma agonists was examined in the metabolically maladapted F(1) pregestational IUGR offspring with a propensity toward pregnancy-induced gestational diabetes. The effect of rosiglitazone maleate [RG; 11 micromol/day from postnatal day (PN) 21 to PN60] vs. placebo (PL) on metabolic adaptations in 2-mo-old F(1) female rats subjected to prenatal (IUGR), postnatal (PNGR), or pre- and postnatal (IUGR + PNGR) nutrient restriction was investigated compared with control (CON). RG vs. PL had no effect on body weight or plasma glucose concentrations but increased subcutaneous white and brown adipose tissue and plasma cholesterol concentrations in all three experimental groups. Glucose tolerance tests with a 1:1 mixture of [2-(2)H(2)]- and [6,6-(2)H(2)]glucose in RG IUGR vs. PL IUGR revealed glucose tolerance with a lower glucose-stimulated insulin release (GSIR) and suppressed endogenous hepatic glucose production (HGP) with no difference in glucose clearance (GC) and recycling (GR). RG PNGR, although similar to PL CON, was hyperglycemic vs. PL PNGR with reduced GR but no difference in the existent low GSIR, HGP, and GC. RG IUGR + PNGR overall was no different from the PL counterpart. Insulin tolerance tests revealed perturbed recovery to baseline from the exaggerated hypoglycemia in RG vs. the PL groups with the only exception being RG PNGR where further worsening of hypoglycemia over PL PNGR was minimal with full recovery to baseline. These observations support that early intervention with RG suppressed HGP in IUGR vs. PL IUGR, without increasing GSIR similar to that seen in CON. Although RG reversed PNGR to the PL CON metabolic state, no such insulin-sensitizing effect was realized in IUGR + PNGR.
产前营养限制伴宫内生长受限(IUGR)改变基础和葡萄糖刺激的胰岛素反应以及肝代谢适应性。研究了代谢失调的 F1 孕前 IUGR 后代中,早期干预胰岛素增敏过氧化物酶体增殖物激活受体γ激动剂对妊娠诱导的妊娠期糖尿病倾向的影响。在 2 月龄 F1 雌性大鼠中,研究了罗格列酮马来酸盐(RG;从产后第 21 天到第 60 天每天 11 微摩尔)与安慰剂(PL)对产前(IUGR)、产后(PNGR)或产前和产后(IUGR+PNGR)营养限制的代谢适应的影响,并与对照组(CON)进行了比较。RG 与 PL 对体重或血浆葡萄糖浓度没有影响,但增加了所有三组实验的皮下白色和棕色脂肪组织以及血浆胆固醇浓度。在 RG IUGR 与 PL IUGR 中,用[2-(2)H2]-和[6,6-(2)H2]-葡萄糖的 1:1 混合物进行的葡萄糖耐量试验显示,葡萄糖耐量降低,胰岛素刺激的胰岛素释放(GSIR)降低,内源性肝葡萄糖产生(HGP)受到抑制,葡萄糖清除率(GC)和再循环(GR)没有差异。尽管 RG PNGR 与 PL CON 相似,但与 PL PNGR 相比,其血糖升高,GR 降低,但 GSIR、HGP 和 GC 低的情况没有差异。总体而言,RG IUGR+PNGR 与 PL 对照组没有差异。胰岛素耐量试验显示,与 PL 组相比,RG 组在低血糖时恢复到基线的情况受到干扰,唯一的例外是 RG PNGR,与 PL PNGR 相比,低血糖进一步恶化的情况最小,可完全恢复到基线。这些观察结果表明,早期干预 RG 抑制了 IUGR 与 PL IUGR 中的 HGP,而不像 CON 中那样增加 GSIR。尽管 RG 使 PNGR 恢复到 PL CON 的代谢状态,但在 IUGR+PNGR 中没有实现这种胰岛素增敏作用。